![Tomas Odergren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tomas Odergren
Directeur Technique/Scientifique/R&D chez
BIOARCTIC AB
Fortune : 217 549 $ au 31/05/2026
Profil
Dr. Tomas Odergren is a Chief Medical Officer at BioArctic AB and a Chairman at NovaSAID AB. Dr. Odergren was previously employed as a Vice President-Clinical Development by Karolinska Development AB, a Principal by AstraZeneca GmbH, and a Non-Executive Director by BioChromix Pharma AB. He also served on the board at Athera Biotechnologies AB, Forendo Pharma Oy, Modus Therapeutics AB, Modus Therapeutics Holding AB and Umecrine Cognition AB. He received his doctorate degree from Karolinska Institutet.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOARCTIC AB CLASS B 0,01 % | 31/12/2024 | 5 700 ( 0,01 % ) | 217 549 $ | 31/05/2026 |
Postes actifs de Tomas Odergren
| Sociétés | Poste | Début |
|---|---|---|
| BIOARCTIC AB | Directeur Technique/Scientifique/R&D | 01/01/2019 |
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology Develops treatments for inflammation and pain in conditions such as rheumatoid arthritis | Président | - |
Anciens postes connus de Tomas Odergren
| Sociétés | Poste | Fin |
|---|---|---|
| KDVENTURES AB | Directeur Technique/Scientifique/R&D | 01/11/2014 |
AstraZeneca GmbH
 AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical drugs | Corporate Officer/Principal | 12/10/2012 |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain | Directeur/Membre du Conseil | - |
Forendo Pharma Oy
 Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health | Directeur/Membre du Conseil | - |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Directeur/Membre du Conseil | - |
Formation de Tomas Odergren
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
23
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Health Technology |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioArctic AB
 BioArctic AB Pharmaceuticals: MajorHealth Technology Develops drugs for patients with disorders of the central nervous systems | Health Technology |
AstraZeneca GmbH
AstraZeneca GmbH Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical drugs | Health Technology |
BioChromix Pharma AB
 BioChromix Pharma AB Miscellaneous Commercial ServicesCommercial Services Provides Alzheimer disease research services | Commercial Services |
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Develops drug for neurological disorders of the brain | Health Technology |
NovaSAID AB
NovaSAID AB Pharmaceuticals: MajorHealth Technology Develops treatments for inflammation and pain in conditions such as rheumatoid arthritis | Health Technology |
Karolinska Development AB
 Karolinska Development AB Financial ConglomeratesFinance Operates as a life sciences investment company | Finance |
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Health Technology |
Modus Therapeutics Holding AB
 Modus Therapeutics Holding AB BiotechnologyHealth Technology Develops sevuparin to treat people suffering from sickle cell disease | Health Technology |
Forendo Pharma Oy
Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage drug company that develops novel treatments in women’s health | Health Technology |
